Stroke genetics - Focus on PDE4D gene

International Journal of Stroke

Volumn 3, Issue 3, 2008, Pages 188-192

  Munshi, Anjana ^a   Kaul, Subhash ^b  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Genetics; Phosphodiesterase 4D gene; Prevention; Stroke

Indexed keywords

PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVD;

BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHROMOSOME 5Q; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ICELAND; MICROSATELLITE MARKER; NONHUMAN; PHARMACOGENOMICS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CONTINENTAL POPULATION GROUPS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; RESEARCH; STROKE;

EID: 48749115278     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2008.00199.x     Document Type: Review

References (43)

1. Whisnant JP: The decline of stroke. Stroke 1984; 15: 160-8.
2. del Zoppo GJ, Hallenbeck JM: Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000; 98: 73-81.
3. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD: Homocysteine and stroke: Evidence on a casual link from mendelian randomisation. Lancet 2005; 365: 224-32.
4. Mancia G: Prevention and treatment of stroke in patients with hypertension. Clin Ther 2004; 26: 631-48.
5. Bak S, Gaist D, Sindrup SH, Skytthe A, Christensen K: Genetic liability in stroke: A long-term follow-up study of Danish twins. Stroke 2002; 33: 769-74.
6. Orlacchio A, Bernardi G: Research actuality in the genetics of stroke. Clin Exp Hypertens 2006; 28: 191-7.
7. Hassan A, Sham PC, Markus HS: Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology 2002; 58: 1483-8.
8. Hassan A, Markus HS: Genetics and ischemic stroke. Brain 2000; 123: 1784-812.
9. Humphries SE, Morgan L: Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 4: 227-35.
10. Dichgans M: Genetics of ischaemic stroke. Lancet Neurol 2007; 6: 149-61.
11. Kostulas K, Huang WX, Crisby M et al. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest 1999; 29: 478-83.
12. Markus HS, Ruigrok Y, Ali N, Powell JF: Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 1998; 29: 1908-11.
13. Morgan L, Humphries SE: The genetics of stroke. Curr Opin Lipidol 2005; 16: 193-9.
14. Hertzberg VS, Stern BJ, Sherman S: Analytic strategies for stroke genetics. J Stroke Cerebrovasc Dis 2002; 11: 272-8.
15. Gretarsdottir S, Thorleifsson G, Reynisdottir ST et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003; 35: 131-8.
16. Brophy VH, Ro SK, Rhees BK et al. Association of phosphodiesterase 4D polymorphism with ischemic stroke in a US population stratified by hypertension status. Stroke 2006; 37: 1385-90.
17. Song Q, Cole JW, O'Connell JR et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: The stroke prevention in young women study. Hum Mol Genet 2006; 15: 2468-78.
18. Bevan S, Markus H: The genetics of stroke. ACNR 2004; 4: 9-11.
19. Liu H, Maurice DH: Phosphorylation-meditated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting. J Bio Chem 1999; 274: 10557-65.
20. Szpirer C, Szpirer J, Rivière M et al. Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP-specific phosphodiesterases 3 and 4. Cytogenet Cell Gene 1995; 69: 11-4.
21. Worrall BB, Aychaleckyj JC: PDE4D and stroke: a real advance or a case of the emperor's new clothes? Stroke 2006; 37: 1955-7.
22. Schubert P, Morino T, Miyazaki H et al. Cascading glia reactions: A common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann NY Acad Sci 2000; 903: 24-33.
23. Gulcher JR, Grétarsdóttir S, Hélgadóttir A, Stefansson K: Genes contributing to risk for common forms of stroke. Trends Mol Med 2005; 11: 217-24.
24. Wang D, Deng C, Bugaj-Gaweda B et al. Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7. Cell Signal 2003; 15: 883-91.
25. Lucas AJ: Atherosclerosis. Nature 2000; 407: 233-41.
26. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
27. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-72.
28. Lõhmussaar E, Gschwendtner A, Mueller JC et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005; 36: 731-6.
29. Bevan S, Porteous L, Sitzer M, Markus HS: Phosphodiesterase 4D Gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 2005; 36: 949-53.
30. Nilsson-Ardnor S, Wiklund PG, Lindgren P et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke 2005; 36: 1666-71.
31. Meschia JF, Brott TG, Brown RD et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005; 58: 351-61.
32. van Rijn MJ, Slooter AJ, Schut AF et al. Familial aggregation, the PDE4D gene and ischemic stroke in a genetically isolated population. Neurology 2005; 65: 1203-9.
33. Saleheen D, Bukhari S, Haider SR et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 2005; 36: 2275-7.
34. Nakayama T, Asai S, Sato N, Soma M: Genotype and haplotype association study of STRK1 region on 5q12 among Japanese: A case-control study. Stroke 2006; 37: 69-76.
35. Woo D, Kaushal R, Kissela B et al. Association of phosphodiesterase 4D with ischemic stroke: A population-based case-control study. Stroke 2006; 37: 371-6.
36. Kuhlenbäumer G, Berger K, Huge A et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German Cohort. J Neurol Neurosurg Psychiatry 2006; 77: 521-4.
37. Staton JM, Sayer MS, Hankey GJ et al. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry 2006; 77: 1067-9.
38. Rosand J, Bayley N, Rost N, de Bakker PI: Many hypotheses but no replication for the association between PDE4D and stroke. Nat Genet 2006; 38: 1091-2.
39. Zee RY, Brophy VH, Cheng S, Hegener HH, Erlich HA, Ridker PM: Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and the risk of ischemic stroke: A prospective, nested case-control evaluation. Stroke 2006; 37: 2012-7.
40. Fidani L, Clarimon J, Goulas A et al. Association of phosphodiesterase 4D gene G0 haplotype and ischaemic stroke in a Greek population. Eur J Neurol 2007; 14: 745-9.
41. Giovannoni MP, Cesari N, Graziano A, Vergelli C, Biancalani C, Biagini P, Dal Piaz V: Synthesis of pyrrolo [2,3-d] pyridazinones as potent, subtype selective PDE4 inhibitors. J Enzyme Inhib Med Chem 2007; 22: 309-18.
42. Mukherjee D, Topol EJ: Pharmacogenomics in cardiovascular diseases. Curr Probl Cardiol 2003; 48: 317-47.
43. Mango R, Vecchione L, Raso B et al. Pharmacogenomics in cardiovascular disease: The role of single nucleotide polymorphisms in improving drug therapy. Expert Opin Pharmacother 2005; 6: 2565-76.